CoChat

Application of a disease‐specific, quality‐of‐life measure (QoL‐AGHDA) in growth hormone‐deficient adults and a random population sample in Sweden: validation of the measure by Rasch analysis

Wirén, L., Whalley, D., McKenna, S., Wilhelmsen, L. · 2000 · Clinical Endocrinology
Cited by 67

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Growth hormone deficiency (GHD) in adults has been associated with impaired health status and quality of life (QoL) in several studies using generic measures, and in a few studies using recently developed disease‐specific measures. Theoretically, disease‐specific measures may be more sensitive and succinct than generic measures, and hence prove convenient for general use in clinical practice. The present study sought to validate the scaling properties of the disease‐specific QoL‐AGHDA measure through the implementation of Rasch analysis. The study also sought to compare, by using the QoL‐AGHDA, the QoL of a relatively large Swedish cohort of adults with untreated GHD with that of a reference population also from Sweden. PATIENTS: The QoL of 111 adults with untreated GHD from Stockholm and Göteborg was compared with that of 1448 adult subjects randomly selected from the population of Göteborg. MEASUREMENTS: The scaling properties of the QoL‐AGHDA were assessed by investigating its fit to a dichotomous Rasch model. Rasch‐transformed QoL scores from the QoL‐AGHDA questionnaire were stratified by age and gender, and 95% confidence intervals were calculated. RESULTS: Rasch analysis of the QoL‐AGHDA indicated the measure to be robust in terms of its unidimensionality and ordering properties, and lack of differential item functioning. The raw scores produced by the QoL‐AGHDA are at the ordinal level. Non‐overlapping 95% confidence intervals of Rasch‐transformed interval scores in most age categories indicated that men and women with GHD had significantly lower QoL than the reference population. CONCLUSION: The Swedish QoL‐AGHDA has good scaling properties, and hence can be considered a robust measure. It is suitable for assessing quality of life in adults with GH deficiency, and for making comparisons with adults who are not growth hormone deficient. Adult GH deficiency is associated with a significant impairment in QoL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.2000.00899.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 67

Metadata

Authors
Wirén, L., Whalley, D., McKenna, S., & Wilhelmsen, L.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2000-02
Volume
52
Issue
2
Pages
143-152
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2144538783
Cited by
67
References
1
FWCI
2.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Application of a disease‐specific, quality‐of‐life measure (QoL‐AGHDA) in growth hormone‐deficient adults and a random population sample in Sweden: validation of the measure by Rasch analysis. https://app.cochat.ai/papers/10.1046/j.1365-2265.2000.00899.x
The paper
Wirén, L., Whalley, D., McKenna, S., & Wilhelmsen, L. (2000). Application of a disease‐specific, quality‐of‐life measure (QoL‐AGHDA) in growth hormone‐deficient adults and a random population sample in Sweden: validation of the measure by Rasch analysis. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2000.00899.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.